The latest report by IMARC Group, titled “Image-guided Therapy Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“. The global image-guided therapy systems market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.

Image-guided therapy systems are sophisticated tools that assist clinicians in planning, performing, and assessing surgical procedures or treatments with precision. These systems integrate medical imaging with surgical or treatment devices, providing real-time visualization that enhances accuracy in interventions. By leveraging technologies such as MRI, CT scans, and ultrasound, image-guided therapy systems help in navigating through the body to target areas requiring intervention with minimal invasiveness. This approach is particularly beneficial in delicate or complex procedures, ensuring that healthy surrounding tissues are preserved while focusing on pathological areas. In recent years, image-guided therapy systems have gained immense traction as an integral component in modern surgical practices and treatment delivery as the enhanced precision and control offered by these systems are crucial in improving patient outcomes.

Request Your Sample Report Now: https://www.imarcgroup.com/image-guided-therapy-systems-market/requestsample

Image-guided Therapy Systems Market Trends and Drivers:

The global image-guided therapy systems market is primarily driven by the increasing demand for minimally invasive surgeries, which offer benefits such as reduced recovery times and lower risk of infection. Besides this, technological advancements are also contributing to market growth, as newer systems provide higher accuracy and better patient outcomes. Additionally, the rising prevalence of chronic diseases where precision treatment is vital, such as cancer, is prompting healthcare providers to adopt these advanced systems. In line with this, the growing geriatric population, which is more prone to conditions requiring surgical interventions. Furthermore, trends such as the integration of artificial intelligence for enhanced decision-making and the push for cost-effective healthcare solutions are accelerating the adoption of image-guided therapy systems worldwide, thus propelling market growth.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

  • Ultrasound Systems
  • Computed Tomography (CT) Scanners
  • Positron Emission Tomography (PET)
  • Endoscopes
  • Magnetic Resonance Imaging (MRI)
  • X-ray Fluoroscopy
  • Others

Breakup by Application:

  • Cardiac Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • Urology
  • Oncology Surgery
  • Gastroenterology
  • Others

Breakup by End Use:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Research and Academic Institutions
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Analogic Corporation
  • Brainlab AG
  • FUJIFILM Holdings Corporation, General Electric Company, Karl Storz SE & Co. KG, Koninklijke Philips N.V., Medtronic plc
  • Siemens Healthineers AG
  • Stryker Corporation and Varian Medical Systems Inc.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal

Related Post